These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24803876)

  • 1. Early detection of hepatocellular carcinoma through surveillance using biomarkers.
    Gish RG
    Gastroenterol Hepatol (N Y); 2014 Feb; 10(2):121-3. PubMed ID: 24803876
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.
    Conti F; Dall'Agata M; Gramenzi A; Biselli M
    Biomark Med; 2015; 9(12):1343-51. PubMed ID: 26580585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.
    Schütte K; Schulz C; Link A; Malfertheiner P
    World J Hepatol; 2015 Feb; 7(2):139-49. PubMed ID: 25729470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
    Lee NP; Cheung ST; Poon RT; Fan ST; Luk JM
    Biomark Med; 2007 Aug; 1(2):273-84. PubMed ID: 20477402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation.
    Gao J; Song P
    Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
    Zhu W; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):308-312. PubMed ID: 33979955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
    Gonzalez SA
    Hepatobiliary Surg Nutr; 2014 Dec; 3(6):410-4. PubMed ID: 25568864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating biomarkers for early detection of hepatocellular carcinoma.
    Beudeker BJB; Boonstra A
    Therap Adv Gastroenterol; 2020; 13():1756284820931734. PubMed ID: 32647536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.
    Sengupta S; Parikh ND
    Hepat Oncol; 2017 Oct; 4(4):111-122. PubMed ID: 30191058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis.
    Toyoda H; Kikuchi K; Tsuruta Y; Hiraoka A; Tsuji K; Tanaka J
    Nephrol Dial Transplant; 2021 May; 36(6):1097-1103. PubMed ID: 33009910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on biomarkers of hepatocellular carcinoma.
    Chaiteerakij R; Addissie BD; Roberts LR
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers.
    Ayoub WS; Steggerda J; Yang JD; Kuo A; Sundaram V; Lu SC
    Ther Adv Med Oncol; 2019; 11():1758835919869120. PubMed ID: 31523283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma surveillance].
    Costentin C
    Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of bone metastases of hepatocellular carcinoma reduces bone fracture and paralysis.
    Hirai T; Shinoda Y; Tateishi R; Asaoka Y; Uchino K; Wake T; Kobayashi H; Ikegami M; Sawada R; Haga N; Koike K; Tanaka S
    Jpn J Clin Oncol; 2019 Jun; 49(6):529-536. PubMed ID: 30957835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options.
    Zapata E; Zubiaurre L; Castiella A; Salvador P; García-Bengoechea M; Esandi P; Arriola A; Beguiristain A; Ruiz I; Garmendia G; Orcolaga R; Alustiza JM
    Rev Esp Enferm Dig; 2010 Jul; 102(8):484-8. PubMed ID: 20670069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma, a unique tumor with a lack of biomarkers.
    Debes JD; Carrera E; Mattos AZ; Prieto JE; Boonstra A;
    Ann Hepatol; 2019; 18(6):786-787. PubMed ID: 31494068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.